BresoTEC Inc., a Canadian company based in Toronto, Ontario, develops, manufactures and sells products for the diagnosis and treatment of sleep disorders and related health conditions. BresoTEC was founded by UHN (University Health Network) and MaRS Innovation.
BresoTEC’s first product, BresoDX®, is an innovative and simple device using acoustic and movement analysis technology to diagnose sleep apnea in the home. BresoDX® received regulatory approval from Health Canada in December 2014 and from the European Commission (CE marking) in February 2016.
Julie Waras Brogren
Chief Operating Officer & VP Global Sales and Marketing